Benzinga's Top #PreMarket Gainers

gained 34.42 percent to $1.070 in pre-market trading after the company reported a proposed acquisition agreement with Midatech Pharma PLC.

shares rose 18.97 percent to $2.76 in pre-market trading after the company received the EU regulatory guidance regarding potential MAA for Tivozanib.

shares climbed 11.69 percent to $4.30 in pre-market trading following the announcement of a development and license deal with SAMSUNG ELECT LTD(F)

.

shares surged 7.55 percent to $37.75 in pre-market trading after the company reported better-than-expected results for the first quarter and raised its FY15 forecast.

shares climbed 5.02 percent to $25.12 in pre-market trading after the company reported the EMA PDCO positive opinion on the Paediatric Investigation Plan for Viaskin Peanut.